United States · Bill · HR
H.R. 1188 (116th)
FLAT Prices Act
Introduced
13 February 2019
Last action
—
Status
Referred to the Subcommittee on Health.
Sponsors
—
Subjects
Discovery layer
Source updated
3 December 2025
Summary
Forcing Limits on Abusive and Tumultuous Prices or the FLAT Prices Act This bill directs the Food and Drug Administration to reduce the market exclusivity of an approved prescription drug if the drug manufacturer increases the drug's price by more than a specified percentage. This reduction may be waived under specified circumstances.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in House (text)
Introduced in House (text)
Introduced in House · EN · 13 February 2019
Introduced in House (PDF)
Introduced in House · EN · 13 February 2019
Introduced in House
summary · EN · 13 February 2019
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/116th-congress/house-bill/1188
- Open data entity: https://api.congress.gov/v3/bill/116/hr/1188